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Accepted 23 April 2012AbstractObjective: Mucinous cystic neoplasm (MCN) of the pancreas occurs mainly in women aged 40e60 years, so it is extremely rare in pregnant
woman.
Case Report: A 28-year-old woman in the ninth week of pregnancy was referred to our hospital due to a tumor of the abdominal cavity.
Abdominal ultrasound demonstrated a huge multicystic lesion in the left upper abdomen. There are mural nodules and hypertrophic septa
partially with the presence of blood flow inside the tumor. Endoscopic ultrasonography was performed and a diagnosis of possible pancreatic
MCN was made. At the second trimester, distal pancreatectomy with splenectomy was performed. Histopathological analysis of the specimen
revealed a pancreatic MCN with severe dysplasia. Immunohistochemically, the tumor was positive for both progesterone and estrogen receptors
in the stromal cell nuclei; moreover, MIB-1 stained positive in 10e20% of the nuclei in the epithelium with severe dysplasia.
Conclusion: MCN carries malignant potential, therefore, early detection and complete surgery is recommended. MCN in pregnancy is rare and
the abdomen is distended during pregnancy, so clinicians can easily miss the presence of the tumor. We should recognize the presence of MCN in
pregnant woman. We speculate that the presence of blood flow within the tumor and MIB-1-positive cells can be a predictor for premalignant or
malignant MCN.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Mucinous cystic neoplasm (MCN) of the pancreas is an
uncommon tumor characterized by mucin-producing columnar
epithelium and a dense ovarian-type stroma [1,2]. MCN
occurs almost exclusively in women aged 40e60 years, so it is
extremely rare in pregnant woman. Pancreatic MCNs have
been reported as potentially sex-hormone-sensitive, such as
estrogen and progesterone, and therefore have rapid growth
during pregnancy [2]. Pancreatic MCN presents a clinical* Corresponding author. Department of Obstetrics and Gynecology, Nagoya
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8550, Japan.
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diameter and presence of mural nodule have been reported as
predictive findings of malignant MCN [4].
In this report, we describe a 28-year-old woman with
a large pancreatic MCN with severe dysplasia during preg-
nancy and also discuss some interesting findings regarding
prediction of premalignant or malignant MCN.
Case report
A 28-year-old gravida 2, para 1 woman in the ninth week of
pregnancy was referred to our hospital due to a tumor of the
abdominal cavity. She had noticed a tumor over the past
several years, but had taken no action. She had no previous
history and no medication before pregnancy. Physicalcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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approximately 15 cm in diameter, in the left upper quadrant.
Abdominal ultrasound demonstrated a huge multicystic lesion
in the left upper abdomen. There are mural nodules and
hypertrophic septa partially with the presence of blood flow
inside the tumor (Fig. 1). Further evaluation by magnetic
resonance imaging showed a multiloculated cystic tumor,
measuring 14 cm  12 cm, with a thick capsule probably
originating from the distal pancreas. Thereafter, endoscopic
ultrasonography was performed and a diagnosis of possible
pancreatic MCN was made. Laboratory tests showed slight
anemia with normal levels of amylase and liver enzymes.
Cancer antigen (CA) 19-9 level was normal (10 U/mL; normal
range: <37 U/mL), but CA125 level was high (76.3 U/mL;
normal range: <35 U/mL). She was advised about possible
prognoses such as fetal intrauterine growth restriction by the
tumor, malignant potential of the tumor, and rupture of the
tumor. A decision was made to resect the tumor at the second
trimester. An operation was performed at 18 þ 3 weeks of
gestation. A laparotomy was performed, and a huge, smooth
cystic tumor was found arising from the body and tail of the
pancreas and adhering to the spleen and retroperitoneum.
Distal pancreatectomy with splenectomy was performed.
The specimen obtained at surgery was multilocular,
15 cm  14 cm, 1110 g. The cystic mass had a smooth
external surface and it was filled with dark yellowish fluid.
Histopathological analysis showed a mucin-producing tall
columnar epithelium lining the inner wall of the cyst, with
ovarian-type stromal tissue (Fig. 2A). The epithelium had
a focal papillary architecture with severe atypia, giving
a diagnosis of pancreatic MCN with severe dysplasia
(Fig. 2B). Immunohistochemical studies showed positive
staining for both progesterone and estrogen receptors in the
stromal cell nuclei (Fig. 2C and D). Moreover, we further
performed immunohistochemical studies using a proliferation
marker, MIB-1, which stained positive in about 10e20% of
the nuclei in the epithelium with severe dysplasia (Fig. 3B).
She was discharged on postoperative day 16. After that, she
suffered from mild glucose intolerance (hemoglobin A1c
level: 6.0%; normal range: 4.3e5.8%; fasting blood glucose
level: 127 mg/dL) at 32 weeks of gestation, but she avoided
any insulin requirement during pregnancy. Otherwise, she had
an uneventful postoperative course, and at 39 þ 4 weeks ofFig. 1. Ultrasound of pancreatic mucinous cystic neoplasm (MCN) performed in
cystic mass (14 cm 11 cm) with septations and mural nodules. (B) Blood flow wgestation, she gave birth by normal vaginal delivery to
a 2980 g healthy baby girl. The placenta weighed 610 g and
gross examination displayed a hypertwisted cord with vela-
mentous insertion. After delivery, she remained disease-free
until the writing of this article, 8 months after surgery.
Discussion
To the best of our knowledge, 17 cases of pancreatic MCN
associated with pregnancy have been reported since the first
report in 1986 [5]. Eight cases were histologically diagnosed
as benign mucinous cystadenoma, whereas six cases were
diagnosed as mucinous cystadenocarcinoma and three as
MCN with dysplasia (also referred to as “borderline tumor”)
[3,6,7]. Our case might be the fourth case of pancreatic MCN
with dysplasia in association with pregnancy (Table 1).
Pancreatic MCNs usually grow slowly, but they sometimes
show rapid growth during pregnancy. It has been reported that
pancreatic MCNs may be responsive to sex hormones,
accounting for their tendency to grow to enormous size
especially during pregnancy [6].
Pancreatic MCNs pose a clinical problem in that they
always carry malignant potential [3]. Also, pregnancy with
a large MCN can be a risk for fetal growth restriction [8].
Therefore, prompt and complete surgery is recommended as
the treatment for MCN [1]. The prognosis for MCNs treated
with complete surgical resection without any additional
treatment is excellent, with a 5-year survival rate of 94% [2].
Generally, the second trimester is believed to be relatively safe
for surgery during pregnancy [3,6]. In fact, our case was MCN
with severe dysplasia, in other words, a premalignant condi-
tion, so we could prevent the progression to malignancy by
performing complete resection during pregnancy.
We reviewed factors believed to predict the malignancy of
MCN. Patients with carcinoma had a significantly larger size
of cyst and higher frequency of mural nodules than those with
adenoma [4]. CA19-9 concentration >37 U/mL has a positive
predictive value of 95.7% for potentially malignant lesions but
a sensitivity of only 35.8% [9]. Carcinoembryonic antigen
concentration >800 ng/mL is a moderately sensitive (48%)
but highly specific (98%) marker for mucinous cystadenoma
or mucinous cystadenocarcinoma [10]. Progesterone stimula-
tion of the stroma in MCNs may actually suppress malignantthe ninth week of gestation. (A) Abdominal ultrasound demonstrating a large
as present around the mural nodule and a hypertrophic septum in the tumor.
Fig. 2. Microscopic pathological features of the resected pancreatic cystic neoplasm. (A) Histopathological examination revealed a pancreatic cyst lined with mucin-
producing columnar epitheliumandwallwith ovarian-type stroma (hematoxylineeosin, 200). (B)Nuclei of the epitheliumwere swollen and the polarity of the nuclei
was disturbed. These findings led to the diagnosis of mucinous cystic neoplasm (MCN) with focal severe dysplasia (hematoxylineeosin, 200). (C, D) Immuno-
histochemical examination revealed ovarian-type stromal cells expressing progesterone receptor (C), and estrogen receptor (D) (original magnification, 100).
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receptors has been correlated with worse outcomes [2]. There
are mural nodules and hypertrophic septa partially with the
presence of blood flow inside the tumor. Generally, blood flow
within the tumor alerts us to the possibility of malignancy.
There are no reports regarding the blood flow in MCNs, but
this finding can indicate the possibility of premalignant or
malignant MCNs. Next, in our case, MIB-1 immunohisto-
chemical staining was positive in the nuclei in the epithelium
with severe dysplasia. This is believed to be the first report to
examine the expression of MIB-1 in MCNs. MIB-1 can
respond to the dividing cells and reflect the aggressiveness ofFig. 3. Immunohistochemical examination of MIB-1 staining of the epithelium of m
at the columnar epithelium without dysplasia (original magnification, 200). (B) M
severe dysplasia (original magnification, 200).cellular proliferation in human neoplasms. Therefore, the
presence of MIB-1 positive cells can be a predictor for
premalignant or malignant MCNs.
In our case, the patient was suffering from mild glucose
intolerance after resection of the pancreatic body and tail, but it
was transient with spontaneous remission. Herring et al [8] have
reported that a patient with mucinous cystadenocarcinoma
developed gestational diabetes after resection of the pancreatic
tail. It is not clear whether resection of the pancreas can be the
etiology of gestational diabetes, but we should be on guard not
only for recurrence of the tumor but also for the occurrence of
gestational diabetes after surgery for MCN.ucinous cystic neoplasm (MCN). (A) Few MIB-1-positive cells were revealed
IB-1 staining was positive in 10e20% of the nuclei in the epithelium with focal
Table 1
Summary of pancreatic mucinous cystic neoplasms (MCNs) with dysplasia in association with pregnancy reported in the literature.
Ref. Age (y) Operation (wk) Size (cm) Pathological diagnosis HR
ER PgR
[3] 30 10 18  14 Moderate dysplasia þ þ
[6] 32 15 15  13 Low grade dysplasia þ þ
[7] 38 2nd trimester 14  14 Borderline ND þ
Our case 28 18 14  12 Severe dysplasia þ þ
ER ¼ estrogen receptor; HR¼ hormone receptor; ND¼ not described; PgR¼ progesterone receptor.
638 H. Tsuda et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 635e638In conclusion, we report a case of MCN with severe
dysplasia during pregnancy. MCN in pregnancy is rare and the
abdomen is distended during pregnancy, so the patient and
medical staff can easily miss the presence of the tumor. MCNs
carry malignant potential, so complete surgery, if possible
during the second trimester, is recommended. We hope that
many obstetricians can keep the clinical features of MCN in
mind. The presence of blood flow within the tumor and of
MIB-1-positive cells can be a predictor for premalignant or
malignant MCN.
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